{"id":104351,"date":"2024-07-30T19:46:00","date_gmt":"2024-07-30T15:46:00","guid":{"rendered":"https:\/\/noortrends.ae\/en\/?p=104351"},"modified":"2024-07-30T23:10:45","modified_gmt":"2024-07-30T19:10:45","slug":"pfizer-shares-leap-following-q1-earnings","status":"publish","type":"post","link":"https:\/\/noortrends.ae\/en\/pfizer-shares-leap-following-q1-earnings\/07\/30\/market-updates\/","title":{"rendered":"Pfizer Shares Leap Following Q1 Earnings"},"content":{"rendered":"\n<p>Pfizer India reported a strong performance in the first quarter, with revenue and profit climbing significantly. Total revenue surged 7% to approximately $73.4 million USD while operating earnings before interest, tax, depreciation, and amortization (EBITDA) soared by 60.31% to $21.4 million USD. Consequently, net profit for the quarter skyrocketed by 61.14% to $18.2 million USD.<br><br>The company attributed part of this exceptional growth to a one-time benefit of approximately $967,000 USD from the Maharashtra VAT Amnesty Scheme. Pfizer opted for this scheme for certain years and received final settlement orders, leading to the reversal of an excess provision.<br><br>Aside from the financial performance, Pfizer India also highlighted its strategic partnership with Glenmark Pharmaceuticals to launch Abrocitinib, a treatment for atopic dermatitis. This drug, already approved in major markets like the US, Japan, and China, is expected to contribute to the company&#8217;s growth trajectory.<br><br>Pfizer shares have been on an upward trend, gaining over 30% since the start of the year and more than 39% in the past twelve months.<br>(\u20b982.00 approximately equals 1 USD)<br><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer India reported a strong performance in the first quarter, with revenue and profit climbing significantly. Total revenue surged 7% to approximately $73.4 million USD while operating earnings before interest, tax, depreciation, and amortization (EBITDA) soared by 60.31% to $21.4 million USD. Consequently, net profit for the quarter skyrocketed by 61.14% to $18.2 million USD.The &hellip;<\/p>\n","protected":false},"author":13,"featured_media":64621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39,36],"tags":[7113,7410],"class_list":["post-104351","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-global-stock-markets","category-market-updates","tag-earnings","tag-pfizer"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/104351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=104351"}],"version-history":[{"count":3,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/104351\/revisions"}],"predecessor-version":[{"id":104359,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/104351\/revisions\/104359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/64621"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=104351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=104351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=104351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}